Claude A. Maurage

Lille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.

Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.

Journal: Neuro-oncology
Published: December 28, 2024

Diagnostic impact of DNA methylation classification in adult and pediatric CNS tumors.

Diagnostic impact of DNA methylation classification in adult and pediatric CNS tumors.

Journal: Scientific reports
Published: November 15, 2024

Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management.

Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management.

Journal: Cell reports. Medicine
Published: September 14, 2023

What's new in the management of meningeal solitary fibrous tumor/hemangiopericytoma?

What's new in the management of meningeal solitary fibrous tumor/hemangiopericytoma?

Journal: Bulletin du cancer
Published: July 08, 2020

Does the medical autopsy still have a place in the current diagnostic process? A 6-year retrospective study in two French University hospitals.

Does the medical autopsy still have a place in the current diagnostic process? A 6-year retrospective study in two French University hospitals.

Journal: Forensic science, medicine, and pathology
Published: September 11, 2019

Close follow-up after discontinuation of cyproterone acetate: a possible option to defer surgery in patients with voluminous intracranial meningioma.

Close follow-up after discontinuation of cyproterone acetate: a possible option to defer surgery in patients with voluminous intracranial meningioma.

Journal: Journal of neurosurgical sciences
Published: November 19, 2016

High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.

High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: October 31, 2015

Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients.

Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients.

Journal: CNS oncology
Published: October 27, 2015

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma.

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma.

Journal: British journal of haematology
Published: February 04, 2015

Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma.

Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma.

Journal: Annals of clinical and translational neurology
Published: January 06, 2015

MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.

MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.

Journal: British journal of haematology
Published: May 14, 2014

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease.

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease.

Journal: Acta neuropathologica communications
Published: January 09, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026